This three-part podcast series on semaglutide provides a comprehensive overview of the drug, starting with its discovery, mechanism of action, and clinical applications in treating type 2 diabetes and obesity. The second episode delves into key clinical trials, highlighting its effectiveness and safety profile, while the final episode explores emerging research, patient experiences, and healthcare provider insights. This series aims to educate listeners on the significant impact of semaglutide in modern medicine and its potential future applications.
Language
🇺🇲
Publishing Since
6/3/2024
Email Addresses
1 available
Phone Numbers
0 available
August 31, 2024
This episode provides a comprehensive overview of semaglutide, a medication used for treating type 2 diabetes and obesity. It covers the drug's mechanism of action, common and serious side effects, contraindications, and important safety considerations. The discussion includes management strategies for side effects, long-term monitoring requirements, and special considerations for different patient populations. This informative guide is valuable for both patients considering semaglutide and healthcare professionals seeking to expand their knowledge about this innovative therapy.
June 29, 2024
This episode explores the groundbreaking medication semaglutide, its impact on type 2 diabetes and obesity treatment, and its future potential. It features patient success stories, insights from healthcare providers, and discussions on emerging research and applications. The episode provides a comprehensive look at how semaglutide is revolutionizing metabolic health management and offers valuable information for patients, healthcare professionals, and anyone interested in medical advancements.
June 29, 2024
This episode provides an in-depth exploration of semaglutide, a groundbreaking medication for treating type 2 diabetes and obesity. It covers major clinical trials, including the SUSTAIN and STEP programs, detailing semaglutide's effectiveness in improving glycemic control and promoting significant weight loss. The episode also discusses the drug's impact on cardiovascular health, its side effect profile, and its potential to revolutionize metabolic health management. Real-world patient experiences and the broader implications for global health are examined, offering a comprehensive look at this important pharmaceutical advancement.
Melissa McAllister
Eva Sheie & Kami Gamlem
The Peptide Queen
Dr. Tyna Moore
Unknown author
Chalene Johnson
Amber Brueseke
Dr. Mark Hyman
Max Lugavere
Jade Teta
Dhru Purohit
Dave Asprey
Kim Carlos
Dr. Gabrielle Lyon
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.